ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The French drug firm Sanofi has struck a deal with the AI start-up BioMap. Sanofi will pay $10 million up front for the California company’s biological map of proteins, which it will use to discover novel targets and to design biologics. This is just the latest deal for Sanofi in the AI space. In a press release, Matt Truppo, the company’s global head of research platforms, says the deal “underscores Sanofi’s commitment to becoming the first pharma company powered by artificial intelligence at scale.”
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X